Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab in Aggravated Airway Inflammation (CRSwNP, Asthma, NERD)
NCT04823585Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Aug 2021
- Primary completion
- Jan 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of mepolizumab in chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, Aspirin Exacerbated Respiratory Disease (AERD), sponsored by Helsinki University Hospital. Started Aug 2021; status: completed.
02
Drugs
mepolizumab
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)asthmaAspirin Exacerbated Respiratory Disease (AERD)
Beyond the preview
Go deeper on NCT04823585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04823585.